Filing Flows › ASP Isotopes (ASPI) › Q1 2025
ASP Isotopes (ASPI) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 20, 2025
ASP Isotopes (ASPI) reported revenue of $1.1M for the first quarter 2025 (Q1 2025), +31% from a year earlier and -8% from the quarter before. Operating margin was -721.6%, net loss $8.5M (767.8% of revenue).
ASP Isotopes, Q1 2025: revenue $1.1M (+31% year over year), operating margin -721.6%, net loss $8.5M, operating cash flow −$3.2M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | -8% | +31% |
| Operating profit | −$8.0M | — | — |
| Net earnings | −$8.5M | — | — |
| Operating cash flow | −$3.2M | — | — |
What changed
Revenue was $1.1M in Q1 2025, up 31% year over year and down 8% from the previous quarter.
Gross margin was 29.7%, down 3.5 points from a year earlier. Operating costs exceeded revenue by $8.0M, an operating margin of -721.6%. Operating expenses grew 36% against revenue growth of 31%. The fastest-growing cost line was Research & development (+611%). The quarter ended with a net loss of $8.5M, narrower than the previous quarter's $9.2M loss.
Operating cash flow was −$3.2M. Non-cash charges added back $149K of depreciation and amortization and $1.9M of share-based compensation. Working capital and other items added $3.3M. Capital expenditures of $2.3M exceeded it, leaving free cash flow of −$5.5M.
Questions
What was ASP Isotopes' revenue in the first quarter 2025?
ASP Isotopes (ASPI) reported revenue of $1.1M for the first quarter 2025 (Q1 2025), +31% from a year earlier and -8% from the quarter before.
Was ASP Isotopes profitable in the first quarter 2025?
Operating loss was $8.0M (-721.6% of revenue) and net loss $8.5M.
Source: ASP Isotopes 10-Q on SEC EDGAR.